Houlihan Lokey (HLI)
Financials · Investment Banking & Brokerage · NYSE
A prominent global independent investment bank focused exclusively on conflict-free financial advisory, restructuring, and M&A services.
What Houlihan Lokey does
Houlihan Lokey is a leading global independent investment bank that provides advisory services in mergers and acquisitions (M&A), capital markets, financial restructuring, and valuation. The firm operates through three primary segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory, serving a diverse client base ranging from mid-cap companies to global corporations and financial sponsors. Unlike many competitors, the firm does not engage in lending, securities sales, or trading, positioning itself as a conflict-free advisor.
Themes: investment banking, mergers and acquisitions (M&A), corporate restructuring, financial advisory, valuation services, capital markets
Fundamentals
- Price$129.05 as of 2026-08-21 close
- Market cap$8.7B as of 2026-08-24
- 1-year return-32.8% 2025-08-21 close $192.02 → 2026-08-21 close $129.05
- P/E21.54 as of 2026-08-24
- Net margin+16.1% as of 2026-08-24
- ROE+17.8% as of 2026-08-24
- Debt / equity0.00 as of 2026-08-24
- Revenue growth (YoY)+1.7% as of 2026-08-24
- Revenue CAGR (3y)+13.1% SEC XBRL
- Beta1.01 as of 2026-08-24
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.1%; at least 2 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How HLI compares in its sector
- price-to-earnings ratiotop 25% 525 covered Financials peers, as of 2026-08-24
- net profit marginmiddle range 538 covered Financials peers, as of 2026-08-24
- operating marginmiddle range 534 covered Financials peers, as of 2026-08-24
- return on equitytop 25% 575 covered Financials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- indicated dividend yieldmiddle range 453 covered Financials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 25% 431 covered Financials peers, as of FY2026
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
HLI is not currently in any published Top 10 list. Its scores are below.
Long-term score
42.9 #738 of 987 scored · #179 of 191 in Financials
Financial health 85th (debt to equity 0, free cash flow margin 19.2%) and profitability 62nd (operating margin 20.4%, return on equity 17.8%); weakest is long-term trend (6th, over the past 12 months this stock lagged the market by 53.3 percentage points).
Short-term score
37.4 #1495 of 1,704 scored · #256 of 277 in Financials
Catalysts 54th: open-market insider buys in 90 days 14, the analyst consensus rating is unchanged since the prior reading; setup 41st: no Elliott-wave labelling currently fits its swings; weakest is trend 24th: a strong downtrend, with sellers in control.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2026)
Covered by reported results. In FY2026, HLI's dividend was covered by reported results (earnings payout 41%, free-cash-flow payout 26%). This describes past coverage, not a forecast.
- Earnings payout41% dividends / net income
- Free-cash-flow payout26% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2026 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Houlihan Lokey looks technically
Houlihan Lokey (HLI) is trading 17.6% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 161 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 26, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 47, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive). It made a new 20-day low about 10 trading days ago. It is 39.1% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 17.6% below its 200-day average, the long-term trend line — a long-term downtrend | -17.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $134.99 | $134.99 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $156.52 | $156.52 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 132.71. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 161 trading days ago — a "death cross", a bearish long-term signal | 161 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 26, with sellers in control | 25.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 47, neither overbought (above 70) nor oversold (below 30) | 47.2 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($122.19 to $133.68) — its "stochastic" reading is 60 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 59.7 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $211.78 | $211.78 |
|---|---|---|
| From the 52-week high | it is 39.1% below its 52-week high (its highest price of the past year) | -39.1% |
| Above the 52-week low | it is 14.4% above its 52-week low (its lowest price of the past year) | +14.4% |
| Below the 52-week high | it is 39.1% below its highest point of the past year | 39.1% |
| Since a 20-day breakout | it made a new 20-day low about 10 trading days ago | 10 sessions |
| Since a 55-day breakout | it made a new 55-day low about 10 trading days ago | 10 sessions |
| All-time high | its highest closing price on record is $211.78 (set on 2025-09-23) | $211.78 |
| Given back of the 52-week move | over the past year its closes ranged ($123.39 to $209.19), and it has recovered only a small part of its fall from last year’s high — 7% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $176.41 to $179.16. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 6.6% |
| From the all-time high | it is 39.1% below its all-time high | -39.1% |
| Nearest price level | it is trading 2.0% below a resistance level at $131.58 — a price it turned at three times since 2026-06-29, most recently on 2026-08-06. Since 2024-08-21 it has 0 such levels below the current price and 12 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +2.0% |
| All-time low | its lowest closing price on record is $18.22 (set on 2015-08-24) | $18.22 |
| Above the all-time low | it is 608.3% above its all-time low | +608.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 70th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $5.02 between its high and its low — about 3.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $5.02 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $118.12 and $140.95 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $118.12 – $129.54 – $140.95 |
| Typical daily range (% of price) | its price moves about 3.9% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.9% |
| Stretch from the 200-day average | it is trading 5.5 daily ranges below its 200-day average price (17.6% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 5.5 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.89× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|---|---|
| Since a bearish engulfing | 7 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 7 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +0.6% |
|---|---|---|
| Open gap | it gapped 13.6% below the previous close 16 sessions ago and has not traded back through the level it left behind at 139.08 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -13.6% |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 10.1 percentage points (the stock lost 7.7% while the market gained 2.3%) | -10.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 17.9 percentage points (the stock lost 14.8% while the market gained 3.1%) | -17.9% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 34.2 percentage points (the stock lost 23.1% while the market gained 11.1%) | -34.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 53.3 percentage points (the stock lost 32.8% while the market gained 20.5%) | -53.3% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: a strong downtrend, with sellers in control, a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 6.4% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 6.3% of the share price. | -6.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 12% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $147.06 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | -12.3% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% above the average price paid since it last reported on 2026-07-30 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $127.40 — a volume-weighted average of daily closes over 17 sessions, not a true tick-by-tick VWAP. | +1.3% |
Price levels it has turned at before
HLI last closed at $129.05 on 2026-08-21. Since 2024-08-21 it has turned at 0 prices below its last close and 12 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $131.58 | Resistance | 2.0% above the last close | turned there three times · 2026-06-29 to 2026-08-06 |
| $134.75 | Resistance | 4.4% above the last close | turned there three times · 2026-03-24 to 2026-06-11 |
| $145.48 | Resistance | 12.7% above the last close | turned there five times · 2026-05-06 to 2026-07-28 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $132.71.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $77.41 and $98.53 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $132.71.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · MACD just crossed bullish (12/26/9) · lagging the market · Printed a doji candle · Trading below the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.27 mean, 1=Strong Buy…5=Strong Sell) — 8 analysts
- Mean price target$153.50 range $145.00 – $177.00; median $152.00
Analyst estimates, as of 2026-08-21. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HLI
- Consensus EPS estimate$1.65 next reporting period, as of 2026-08-21
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on market conditions for M&A and restructuring activity, which are inherently cyclical.","Ability to attract and retain highly qualified financial professionals in a competitive labor market.","Reputational risk associated with the quality and independence of advisory services."]
What changed in the latest 10-Q
AI-assisted comparison of HLI's 10-Q filed 2026-02-03 against the prior one filed 2025-11-04.
Management's Discussion & Analysis (MD&A)
- Added:
- Added text in newer filing (2026-02-03): 'In connection with certain acquisitions, certain employees may be entitled to deferred consideration, primarily in the form of retention payments, should certain service and/or performance conditions be met in the future. As a result of these conditions, such deferred consideration would be expensed as compensation in current and future periods and has been accrued as liabilities on the Consolidated Balance Sheets as of December 31, 2025 and March 31, 2025.'
- Removed:
- Removed from older filing (2025-11-04): 'In connection with certain acquisitions, certain employees may be entitled to deferred consideration, primarily in the form of retention payments, should certain service and/or performance conditions be met in the future. As a result of these conditions, such deferred consideration would be expensed as compensation in current and future periods and has been accrued as liabilities on the Consolidated Balance Sheets as of December 31, 2025 and March 31, 2025.'
- Removed from older filing (2025-11-04): sentence about certain annual equity-based bonus awards granted prior to December 31, 2024 including fixed share compensation awards and liability classified fixed dollar awards, and text about cash bonuses accrued monthly
- Reworded:
- Newer filing (2026-02-03) uses 'We are under no duty to, and we do not undertake any obligation to, update' while older filing (2025-11-04) uses 'We are under no duty to and we do not undertake any obligation to update' (comma added after 'to')
- Notes:
- The older filing text appears truncated at the end, cutting off mid-sentence regarding cash bonuses. Comparison of compensation expense discussion is therefore incomplete for the full section.
Risk Factors
- Added:
- Newer filing (2026-02-03) added 'Item 1A. Risk Factors' page number changed from 28 to 29
- Newer filing presents balance sheet data as of December 31, 2025 compared to September 30, 2025 in older filing
- Newer filing presents consolidated statements of comprehensive income for nine months ended December 31, 2025 (compared to six months ended September 30, 2025 in older filing)
- Newer filing includes quarterly period ended December 31, 2025 (three months) with revenues of $717,072 thousand
- Newer filing cash flow statement covers nine months ended December 31, 2025 (compared to six months ended September 30, 2025)
- Newer filing shows consolidated statements of changes in stockholders' equity with quarterly balances at December 31, 2025 and October 1, 2025
- Newer filing shows nine-month net income of $325,862 thousand versus $277,791 thousand in comparative 2024 period
- Removed:
- Older filing (2025-11-04) presented balance sheet data as of September 30, 2025
- Older filing presented consolidated statements of comprehensive income for six months ended September 30, 2025
- Older filing included quarterly period ended September 30, 2025 with revenues of $659,452 thousand
- Older filing cash flow statement covered six months ended September 30, 2025
- Older filing showed consolidated statements of changes in stockholders' equity with quarterly balances at September 30, 2025 and July 1, 2025
- Older filing showed six-month net income of $209,314 thousand versus $182,489 thousand in comparative 2024 period
- Reworded:
- Balance sheet comparison dates changed from 'September 30, 2025' and 'March 31, 2025' to 'December 31, 2025' and 'March 31, 2025'
- Statement of comprehensive income periods changed from 'Three Months Ended September 30' and 'Six Months Ended September 30' to 'Three Months Ended December 31' and 'Nine Months Ended December 31'
- Cash flows statement period changed from 'Six Months Ended September 30, 2025' to 'Nine Months Ended December 31, 2025'
- Stockholders' equity statement balances changed from 'July 1, 2025' opening and 'September 30, 2025' closing to 'October 1, 2025' opening and 'December 31, 2025' closing
- Notes:
- The two filings represent different quarters: Q2 fiscal 2026 (ended September 30, 2025) versus Q3 fiscal 2026 (ended December 31, 2025), resulting in different financial statement periods and comparative data
- Text was truncated in the cash flows section for both filings, limiting comparison completeness for that section
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 0 open-market sales by insiders in the last 90 days.
- Last 30 days1 buy ($500570) · 0 sells — 1 buying insider
- Last 90 days1 buy ($500570) · 0 sells — 1 buying insider
- Last 180 days1 buy ($500570) · 1 sell ($941379) — 1 buying, 1 selling insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-03. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HLI's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 3 matched disclosures for HLI from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding HLI as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 8,349,021
- Reported value $1,199,086,336
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
HLI had 2,190,756 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for HLI because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 2,190,756
- Prior settlement (shares) 1,778,379
- Reported change 23.19%
- Days to cover (reported) 2.16
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Evercore (EVR)
- Moelis & Company (MC)
- Lazard (LAZ)
- PJT Partners (PJT)
- Perella Weinberg Partners (PWP)
- Centerview Partners
- Goldman Sachs (GS)
- JPMorgan Chase (JPM)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HLI vs…
Houlihan Lokey is found in…
Frequently asked questions
What does Houlihan Lokey (HLI) do?
Houlihan Lokey is a leading global independent investment bank that provides advisory services in mergers and acquisitions (M&A), capital markets, financial restructuring, and valuation. The firm operates through three primary segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory, serving a diverse client base ranging from mid-cap companies to global corporations and financial sponsors.
What sector is Houlihan Lokey (HLI) in?
Houlihan Lokey (HLI) is classified in the Financials sector. Its industry is Investment Banking & Brokerage. It trades on NYSE.
Does HLI pay a dividend?
Yes — Houlihan Lokey (HLI) pays a dividend, with an indicated yield of about 2.08% and at least 2 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Houlihan Lokey's (HLI) competitors?
Notable peers of Houlihan Lokey (HLI) include Evercore, Moelis & Company, Lazard, PJT Partners and Perella Weinberg Partners. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in HLI?
Yes — we hold 3 matched STOCK Act disclosures for HLI from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Houlihan Lokey (HLI) overbought or oversold right now?
Houlihan Lokey (HLI) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 47, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HLI come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.